Should we stop taking thiazides to prevent kidney stones?

Published Date: 08 Mar 2023

"Thiazide is the standard treatment for calcium stones, so this [new research] has the potential to upset the basket," one observer said.

Read Full News

Latest News

Some US Medical Schools to Teach Nutrition Under Government Deal

About a fourth of U.S. medical schools will expand their nutrition education offerings this autumn as part of a ⁠deal with the administration of President Donald Trump, said...

China Approves Pfizer GLP-1 Drug for Weight Loss

China has approved Pfizer's GLP-1 treatment Xianweiying for long-term weight management in ⁠overweight or obese adults, the U.S. drugmaker said on Friday.

Roche, Zealand's Obesity Drug Shows Up to 10.7% Weight Loss in Mid-stage Trial

Roche said on Thursday its experimental obesity drug, which it is developing with Denmark's Zealand Pharma, helped patients ⁠lose up to 10.7% of their body weight in a...

Autonomic Dysfunction: A Hidden Driver of Gastroparesis?

Multimodal physiologic testing in patients with chronic gastroduodenal symptoms reveals autonomic dysfunction and links it to delayed gastric emptying.

Tendon Rupture Risk Linked With GLP-1 Use in Obese Patients

5-year findings call for physicians to balance the benefits of the medication for weight loss with the rupture risks, particularly for tendons that do the heavy lifting.

FDA Extends Approval of PKU Drug to Include Adolescents

Previously only approved for adults, BioMarin’s pegvaliase-pqpz (PALYNZIQ) is now licensed for patients as young as 12 years.

Todays Updates

Neoadjuvant GOLP Boosts Event-Free Survival in Liver Cancer

A phase 2/3 trial evaluates the efficacy and safety of neoadjuvant therapy with gemcitabine-oxaliplatin, lenvatinib, and toripalimab in patients with high-risk intrahepatic cholangiocarcinoma.

Risk Factors Driving Severe Maternal Morbidity in the US

Hypertensive disorders of pregnancy, chronic hypertension, and obesity are the primary risk factors for severe maternal morbidity.

CUD, Depression Share Bidirectional Link

Cannabis use disorder has a bidirectional and clinically meaningful association with major depressive disorder, new research suggests.

Medicaid Expansion Tied to Pancreatic Cancer Survival

A new cohort study suggests that Medicaid expansion is associated with a lower mortality risk among patients with pancreatic cancer.

Can Upadacitinib Improve Sleep Quality in Patients With RA?

Upadacitinib may improve self-reported sleep quality at 3 months in patients with rheumatoid arthritis, with sustained benefits seen over the long term.

Novel Drug Duo Preserves Bladder in Muscle-Invasive Cancer

Approximately 40% of patients with muscle-invasive bladder cancer achieve a clinical complete response after neoadjuvant sacituzumab govitecan plus pembrolizumab, the SURE-02 trial finds.

Exploring Whether GLP-1 Medications May Cause Sinusitis

Research is limited, but what has been done shows a possible connection.

Todays Updates

Neoadjuvant GOLP Boosts Event-Free Survival in Liver Cancer

A phase 2/3 trial evaluates the efficacy and safety of neoadjuvant therapy with gemcitabine-oxaliplatin, lenvatinib, and toripalimab in patients with high-risk intrahepatic cholangiocarcinoma.

Risk Factors Driving Severe Maternal Morbidity in the US

Hypertensive disorders of pregnancy, chronic hypertension, and obesity are the primary risk factors for severe maternal morbidity.

CUD, Depression Share Bidirectional Link

Cannabis use disorder has a bidirectional and clinically meaningful association with major depressive disorder, new research suggests.

Medicaid Expansion Tied to Pancreatic Cancer Survival

A new cohort study suggests that Medicaid expansion is associated with a lower mortality risk among patients with pancreatic cancer.

Can Upadacitinib Improve Sleep Quality in Patients With RA?

Upadacitinib may improve self-reported sleep quality at 3 months in patients with rheumatoid arthritis, with sustained benefits seen over the long term.

Novel Drug Duo Preserves Bladder in Muscle-Invasive Cancer

Approximately 40% of patients with muscle-invasive bladder cancer achieve a clinical complete response after neoadjuvant sacituzumab govitecan plus pembrolizumab, the SURE-02 trial finds.

Exploring Whether GLP-1 Medications May Cause Sinusitis

Research is limited, but what has been done shows a possible connection.

Latest News

About a fourth of U.S. medical schools will expand their nutrition education offerings this autumn as part of a ⁠deal with the administration of President Donald Trump, said...

China has approved Pfizer's GLP-1 treatment Xianweiying for long-term weight management in ⁠overweight or obese adults, the U.S. drugmaker said on Friday.

Roche said on Thursday its experimental obesity drug, which it is developing with Denmark's Zealand Pharma, helped patients ⁠lose up to 10.7% of their body weight in a...

Multimodal physiologic testing in patients with chronic gastroduodenal symptoms reveals autonomic dysfunction and links it to delayed gastric emptying.

5-year findings call for physicians to balance the benefits of the medication for weight loss with the rupture risks, particularly for tendons that do the heavy lifting.

Previously only approved for adults, BioMarin’s pegvaliase-pqpz (PALYNZIQ) is now licensed for patients as young as 12 years.

News All Time

US FDA Warns 30 Telehealth Firms Over Misleading Ads for Compounded Weight‑loss Drugs

The U.S. Food and Drug Administration has issued warning letters to 30 telehealth companies for making false or misleading ⁠claims about compounded versions of popular GLP-1...

US FDA Warns Novo Again About Misleading Drug Advertising

The U.S. Food and Drug Administration has warned Novo Nordisk over a consumer ad for its blockbuster diabetes drug, ⁠Ozempic, saying the commercial makes false and...

Scenarios Show How to Plan for Osteoporosis Drug Sequences

Gina Woods, MD, shares three case scenarios of sequential treatment decision-making for long-term therapy and discusses research that can inform clinical decisions.

Does HRT Lower Osteoporosis Risk?

New research suggests early initiation of hormone replacement therapy could protect bone health.

HRT Patches Superior to Oral Meds for FHA-Related Bone Loss

With the risk for bone fracture high in patients with amenorrhea caused by anorexia or excessive exercise, studies show transdermal HRT provides more favorable bone benefits than oral HRT.

Aardvark Pauses Late-stage Trial Testing Rare Disease Treatment

Aardvark Therapeutics is voluntarily pausing its late-stage trial testing its experimental treatment for a ⁠type of rare genetic disease after it found heart-related side...

Treat Aging, Not Diseases, to Extend Healthspan

Targeting aging rather than individual diseases could add more than a decade of healthy life, researchers say, citing centenarian studies and drug repurposing efforts.

FDA Okays New Indications for Once-Weekly Growth Hormone

Novo Nordisk’s Sogroya is now approved for children aged 2.5 or older with idiopathic short stature, small for gestational age, and Noonan Syndrome.

Daily Oral Option for Acromegaly Wins EU Backing

Palsonify, a once-daily oral SST2 agonist, offers a noninvasive alternative to monthly depot injections, long considered the standard medical therapy for acromegaly.

Patient-Centered Approaches in Obesity Case Management

Nonjudgmental and collaborative care plans are ideal for primary care clinicians treating patients with obesity.

Widely Used Procedure Questionable for Pancreatitis Patients

Pivotal study shows no clear benefit for the common endoscopic procedure in this patient group. Experts say the new data could help avoid unnecessary cost and risk.

Can OTC Remedies Help With GLP-1 Adherence?

GI side effects from GLP-1s may cause patients to drop the medications or turn to OTC remedies. Gastroenterologists don’t rule them out but also cite lack of evidence.

Novel GLP-1 Promising for Reducing Weight, Glucose

A new GLP-1 drug showed superior efficacy in reducing A1c and weight in patients with T2D.

Problems Arise at the Intersection of Alcohol and GLP-1s

Alcohol often blocks or counters the effects of weight-loss drugs and taxes liver and kidney function.

Changes in Body Image and Pain Tied to Depression in Cushing

A recent longitudinal cohort study shows a statistically significant relationship between body image disturbance, pain, and persistent depression in patients with Cushing syndrome.

Recommended News For You

An inoperable locally advanced NSCLC trial dubbed "Practice Changing".

Extracellular matrix pathway emerges as treatment target for pediatric cancer

Novel radiotracer identifies biomarker for triple-negative breast cancer

Celebrity Cancers Stoking Fear? Cisplatin Shortage Ends; Setback for Anti-TIGIT

Overdosing on Chemotherapy: A Single Gene Test Could Prevent Hundreds of Deaths Annually.

From 40 to 74, the US Preventive Services Task Force advises every two years for screening mammography.

Nearly 4 million lung cancer deaths averted and 76 million years of life gained due to tobacco control in US

Recommended Articles For You

The Predictive Power of Theranostics in Palliative Neuroendocrine Tumor Management 

Understanding Dasatinib: A Promising Drug for Cancer Treatment  

From Diagnosis to Recovery: A Comprehensive Guide to Dealing with Cystic Teratoma 

The Potential of Amifostine in Cancer Treatment: A Revolutionary Breakthrough 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Colon cancer and exercise: Can physical activity reprogram genes?

2.

Distribution of fat could influence cancer risk, study suggests

3.

Effective for localizing small, non-palpable breast lesions is ultrasound-guided localization with magnetic seeds.

4.

EBV Screening Tied to Lower Nasopharyngeal Cancer Mortality Risk

5.

Women who miss their first mammogram face higher risk of breast cancer death, study finds

1.

Myeloproliferative Disorders: Causes, Symptoms and Treatment Options 

2.

Unlocking the Potential of Pirtobrutinib: A New Frontier in Cancer Treatment

3.

Tremelimumab: A Potential Breakthrough in Cancer Treatment

4.

Exploring the Latest Advances in PTLD Cancer Treatment

5.

The Importance of Balanced Potassium Levels in Maintaining Good Health

1.

International Lung Cancer Congress®

2.

Future NRG Oncology Meeting

3.

Genito-Urinary Oncology Summit 2026

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2

2.

What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?

3.

INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients

4.

Current Scenario of Blood Cancer- Further Discussion on Genomic Testing & Advancement in Diagnosis and Treatment

5.

An Eagles View - Evidence-based discussion on Iron Deficiency Anemia

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot